---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-034254"
form_type: "8-K"
ticker: "SMNR"
cik: "0001913577"
company_name: "Semnur Pharmaceuticals, Inc."
filed_at: "2025-04-22T23:59:59+00:00"
generated_at: "2026-05-23T09:37:08.285503+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Denali Capital amends merger pact with Semnur; extends deadline to Sept 2025, addresses Nasdaq delisting

## Summary
- Amendment allows Denali to extend business combination deadline to Dec 11, 2025, or later if mutually agreed.
- Outside Date for closing merger extended to Sept 30, 2025; if extension effective, Outside Date becomes Extension Date.
- Modifies covenants to address Denali's Nasdaq delisting and subsequent OTC Markets quotation of its securities.
- Denali will use reasonable best efforts to list its units, shares, and warrants on OTC Markets after Nasdaq delisting.
- Other changes include updating blank-check company status and proxy statement requirements for shareholder vote.

## SEC filing metadata
- accession: 0001213900-25-034254
- form_type: 8-K
- ticker: SMNR
- cik: 0001913577
- company_name: Semnur Pharmaceuticals, Inc.
- filed_at: 2025-04-22T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1913577/000121390025034254/0001213900-25-034254-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1913577/000121390025034254/ea0239156-8k_denali.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-034254
- JSON: https://secwatch.observer/filing/0001213900-25-034254.json
- Plain text: https://secwatch.observer/filing/0001213900-25-034254.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.